Lead article
Oblique view
2002, Volume 09, Issue 01, pages 1-56
Acute & Interventional Cardiology 2002; Volume 9: pages AIC 1- AIC 32
Heart & Brain 2003; Volume 10, Issue 1: pages HB 1 - HN 24
ACS management
Cardiovascular Research 2018 Handbook
CT coronary angiography with HeartFlow®
News and views
Opinion
2002, Volume 09, Issue 02, pages 57-124
2013, Volume 20 (online first)
Acute & Interventional Cardiology 2003; Volume 10: pages AIC 1- AIC 88
Amyloid heart disease
Online First
2002, Volume 09, Issue 03, pages 125-184
2014, Volume 21 (online first)
Acute & Interventional Cardiology 2004; Volume 11: pages AIC 1- AIC 104
Angina book form
Book review
Angiography
Ad test
2002, Volume 09, Issue 04, pages 185-244
2002, Volume 09, Supplement 7: Early thrombolysis – the realities and the practicalities
2015, Volume 22 (online first)
Acute & Interventional Cardiology 2005; Volume 12: pages AIC 1- AIC 104
Correspondence
Angina
Acute and Interventional Cardiology
2002, Volume 09, Issue 05, pages 245-304
2002, Volume 09, Supplement 8: Management of acute coronary artery disease
Acute & Interventional Cardiology 2006; Volume 13: pages AIC 1- AIC5 6
Course review
Anticoagulation
2016, Volume 23 (online first)
Clinical articles
2002, Volume 09, Issue 06, pages 305-368
2003, Volume 10, Supplement 1: Diet and heart health: emerging evidence
ECGs for the fainthearted
2017, Volume 24 (online first)
Diabetes and CVD
2002, Volume 09, Issue 07, pages 369-424
2003, Volume 10, Supplement 2: Socratic dialogue: the future management of hyperlipidaemia
In brief
Heart failure
COVID-19
diabetes
2002, Volume 09, Issue 08, pages 425-492
2003, Volume 10, Supplement 3: Drug treatment of hypertension – the future is combination therapy
Meeting report
Heart valve disease
Editorials
2002, Volume 09, Issue 09, pages 493-560
2003, Volume 10, Supplement 4: Phosphodiesterase type 5 (PDE5) inhibitors: looking beyond erectile dysfunction
Hyperkalaemia
2020, Volume 27, (online first)
Featured article
2002, Volume 09, Issue 10, pages 561-644
2004, Volume 11, Supplement 1: Diet and heart health symposium II
Lipids
2021, Volume 28, (online first)
Heart and Brain
Obesity
2004, Volume 11, Supplement 2: Improved cardiovascular risk reduction: the evidence for raising HDL cholesterol
Learning
2004, Volume 11, Supplement 3: A new class in cholesterol management
Pulmonary hypertension
Learning Articles
Standalone learning with reflection modules
2003, Volume 10, Issue 01, pages 1-76
2005, Volume 12, Supplement 1: This House believes that the UK healthcare system may be failing as many as 50% of patients with hyperlipidaemia by not reducing their cholesterol to effective levels
Supplements
2003, Volume 10, Issue 02, pages 77-160
2005, Volume 12, Supplement 2: National Institute for Clinical Excellence (NICE) recommendations on the use of myocardial perfusion scintigraphy
2003, Volume 10, Issue 03, pages 161-240
2006, Volume 13, Supplement 1: Switching statins: what are the issues and implications?
Books
Videos
2003, Volume 10, Issue 04, pages 241-320
2006, Volume 13, Supplement 2: The role of angiotensin-converting enzyme inhibitors in coronary artery disease
Volumes
2003, Volume 10, Issue 05, pages 321-400
2007, Volume 14, Supplement 1: Best practice principles for cholesterol lowering
2003, Volume 10, Issue 06, pages 401-488
2004, Volume 11, Issue 01, pages 1-80
2007, Volume 14, Supplement 3: Optimising global risk reduction: insights from REACH
2004, Volume 11, Issue 02, pages 81-168
2007, Volume 14, Supplement 4: Direct renin inhibition with aliskiren – a new option in treating hypertension
2004, Volume 11, Issue 03, pages 169-256
2008, Volume 15, Supplement 1: Clinical implications of the inhibition of the late sodium current: a new paradigm in the treatment of ischaemic heart disease
2004, Volume 11, Issue 04, pages 257-332
2008, Volume 15, Supplement 2: Cholesterol management
2004, Volume 11, Issue 05, pages 333-412
2009, Volume 16, Supplement 1: Moving forward in pulmonary arterial hypertension
2004, Volume 11, Issue 06, pages 413-496
2009, Volume 16, Supplement 2: Maximising safety and efficacy in the treatment of wet AMD
2005, Volume 12, Issue 01, pages 1-80
2009, Volume 16, Supplement 3: Multi-management of ischaemic heart disease: do we have the COURAGE of our convictions?
2005, Volume 12, Issue 02, pages 81-160
2010, Volume 17, Supplement 1: Aspirin – reassessing its role in cardiovascular disease
2005, Volume 12, Issue 03, pages 161-244
2010, Volume 17, Supplement 2: Are all angiotensin receptors blockers the same?
2005, Volume 12, Issue 04, pages 245-320
2010, Volume 17, Supplement 3: PCI in the UK – the continuing journey
2005, Volume 12, Issue 05, pages 321-404
2011, Volume 18, Supplement 1: Setting the standard for cardiac rehabilitation
2005, Volume 12, Issue 06, pages 405-476
2011, Volume 18, Supplement 2: Anaemia in chronic heart failure: what constitutes optimal investigation and treatment?
2006, Volume 13, Issue 01, pages 1-76
2011, Volume 18, Supplement 3: The management of stable angina – a perspective on recent guidance
2006, Volume 13, Issue 02, pages 77-156
2012, Volume 19, Supplement 1: Lipids and CVD: improving practice and clinical outcome
2006, Volume 13, Issue 03, pages 157-224
2012, Volume 19, Supplement 2: Chronic stable angina guidelines – is there an emerging international consensus?
2006, Volume 13, Issue 04, pages 225-300
2006, Volume 13, Issue 05, pages 301-372
2013, Volume 20, Supplement 1: Optimising hypertension treatment: NICE/BHS guideline implementation and audit for best practice
2006, Volume 13, Issue 06, pages 373-440
2013, Volume 20, Supplement 2: Acute heart failure – a call to action
2007, Volume 14, Issue 01, pages 1-60
2013, Volume 20, Supplement 3: Cardiovascular health and disease prevention in clinical practice
2007, Volume 14, Issue 02, pages 61-120
2014, Volume 21, Supplement 1: Rivaroxaban in non-valvular atrial fibrillation: European experience
2007, Volume 14, Issue 03, pages 121-180
2014, Volume 21, Supplement 2: Unlocking the potential of NOACs
2007, Volume 14, Issue 04, pages 181-244
2015, Volume 22, Supplement 1: Pulmonary hypertension in UK clinical practice – an update
2007, Volume 14, Issue 05, pages 245-296
2016, Volume 23, Supplement 1: Perspectives in chronic heart failure – new treatment advances
2016, Volume 23, Supplement 2: The future of cardioversion management – new strategies for the use of oral anticoagulation in direct current cardioversion
2008, Volume 15, Issue 01, pages 1-56
2017, Volume 24, Supplement 1: Optimising the management of post-ACS patients
2008, Volume 15, Issue 02, pages 57-112
2018, Volume 25, Supplement 1: Anticoagulation in atrial fibrillation: focus on PIONEER AF-PCI and its implications
2008, Volume 15, Issue 03, pages 113-168
2018, Volume 25, Supplement 2: Management of cardiovascular disease in the patient with diabetes
2008, Volume 15, Issue 04, pages 169-216
2018, Volume 25, Supplement 3: Advances in cardiac pacing – A 60th anniversary update
2008, Volume 15, Issue 05, pages 217-272
2019, Volume 26, Supplement 1: Advances in the treatment of chronic heart failure with reduced ejection fraction in real-world settings
2008, Volume 15, Issue 06, pages 274-328
2009, Volume 16, Issue 01, pages 1-48
2019, Volume 26, Supplement 2: Edoxaban – insights from pivotal studies and sub-analyses
2009, Volume 16, Issue 02, pages 49-104
2020, Volume 27, Supplement 1: Peripheral artery disease in the UK – unmet needs
2009, Volume 16, Issue 03, pages 105-152
2020, Volume 27, Supplement 2: Adapting cardiovascular disease care to the ‘new norm’ of the COVID-19 era – same standard, different delivery
2009, Volume 16, Issue 04, pages 153-200
2021, Volume 28, Supplement 1: Iron deficiency in heart failure
2009, Volume 16, Issue 05, pages 201-256
2009, Volume 16, Issue 06, pages 257-304
2010, Volume 17, Issue 01, pages 1-48
2010, Volume 17, Issue 02, pages 49-96
2010, Volume 17, Issue 03, pages 97-152
2010, Volume 17, Issue 04, pages 153-200
2010, Volume 17, Issue 05, pages 201-248
2010, Volume 17, Issue 06, pages 250-296
2011, Volume 18 Issue 01, pages 1-48
2011, Volume 18 Issue 02, pages 49-96
2011, Volume 18 Issue 03, pages 97-144
2011, Volume 18 Issue 04, pages 145-192
2011, Volume 18, Issue 5/6, pages 195-248
2012, Volume 19, Issue 1, pages 01-48
2012, Volume 19, Issue 2, pages 49-96
2012, Volume 19, Issue 3, pages 97-144
2012, Volume 19, Issue 4, pages 145-184
2013, Volume 20, Issue 1, pages 5-40
2013, Volume 20, Issue 2, pages 41-80
2013, Volume 20, Issue 3, pages 81-120
2013, Volume 20, Issue 4, pages 121-160
2014, Volume 21, Issue 1, pages 1–40
2014, Volume 21, Issue 2, pages 41–80
2014, Volume 21, Issue 3, pages 81–120
2014, Volume 21, Issue 4, pages 121–160
2015, Volume 22, Issue 1, pages 1–40
2015, Volume 22, Issue 2, pages 41–80
2015, Volume 22, Issue 3, pages 81–120
2015, Volume 22, Issue 4, pages 121–160
2016, Volume 23, Issue 1, pages 1–40
2016, Volume 23, Issue 2, pages 41–81
2016, Volume 23, Issue 3, pages 81–120
2016, Volume 23, Issue 4, pages 121–160
2017, Volume 24, Issue 1, pages 1–40
2017, Volume 24, Issue 2, pages 41–80
2017, Volume 24, Issue 3, pages 81–120
2017, Volume 24, Issue 4, pages 121–160
2018, Volume 25, Issue 1, pages 1–40
2018, Volume 25, Issue 2, pages 41–80
2018, Volume 25, Issue 3, pages 81–120
2018, Volume 25, Issue 4, pages 121–160
2019, Volume 26, Issue 1, pages 1–40
2019, Volume 26, Issue 2, pages 41–80
2019, Volume 26, Issue 3, pages 81–120
2019, Volume 26, Issue 4, pages 121–160
2020, Volume 27, Issue 1, pages 1–40
2020, Volume 27, Issue 2, pages 41–72
2020, Volume 27, Issue 3, pages 73–104
2020, Volume 27, Issue 4, pages 105–144
2021, Volume 28, Issue 1, pages 1–40
